Who we are

AuriSense is a healthcare technology company developing integrated neuromonitoring systems that translate physiological signals into actionable clinical insight across a range of acute and emergent conditions. By combining a noninvasive sensing device with intelligent software that captures, processes, and interprets neurological and autonomic signaling, AuriSense delivers a unified platform designed to support timely, informed decision-making when conventional diagnostic resources are limited.

The AuriSense platform focuses on converting complex physiological data into clear, interpretable outputs that can assist with assessment, triage, and escalation of care. The system is designed to operate rapidly, function offline, and integrate smoothly into existing clinical workflows, enabling practical use across diverse care settings without adding complexity or burden to frontline teams.

AuriSense is currently advancing its technology through early development and validation in collaboration with clinical and engineering partners. Additional information about the platform and its applications will be shared as development progresses.

Our Team

Jai Thakor, MHS, PMP

Founder & CEO

Daniel Swedien, MD

Clinical Director

David Sherman, PhD

Principal Investigator

Laura Rice, PhD

Regulatory Lead

Medical Advisors

Sung-Min Cho, DO, MHS

Associate Professor, Neurology, Surgery, Anesthesiology & Critical Care, Johns Hopkins University

Raj Mukherjee, MD, MPH

Associate Professor, Neurosurgery, Johns Hopkins University

Eva Ritzl, MD

Professor, Neurology, Weill Cornell Medicine

Henry Brem, MD

Professor, Neurosurgery, Johns Hopkins University

Business Advisors

Abhishek Rege, PhD

CEO, Vasoptic

Steve Weisner

CEO, Nihon Kohden Innovation Center

Rutwik Ghodadra, MBA

CEO, Guidepoint Insights Services